It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
This study aims to evaluate the effectiveness of upper pole calyx fornix subapical puncture in percutaneous nephrolithotomy (PCNL) compared to traditional middle calyx puncture. The subapical puncture technique offers the advantages of upper pole access while minimizing the risk of pleural injury.
Methods
We conducted a retrospective analysis of 194 patients who underwent PCNL at our hospital from May 2022 to November 2023. Patients were divided into two groups based on puncture technique: the Upper-PCNL group (n = 122) with upper pole calyx fornix subapical puncture and the Mid-PCNL group (n = 72) with middle calyx fornix apex puncture. Data collected included tract establishment time, operative time, stone-free rates, complications, and auxiliary procedures.
Results
The Upper-PCNL group demonstrated significantly higher primary stone-free rates (83.6% vs. 69.4%, P = 0.021) and shorter operative times (59.99 ± 5.85 min vs. 68.49 ± 6.74 min, P < 0.001) compared to the Mid-PCNL group. Tract establishment time was also significantly shorter in the Upper-PCNL group (3.06 ± 0.35 min vs. 3.56 ± 0.66 min, P < 0.001). The hemoglobin drop was not significantly different between the groups. Complication rates were minimal and similar between groups. None of the patients in the Upper-PCNL group experienced pleural, liver, or spleen injuries.
Conclusions
Upper pole calyx fornix subapical puncture achieved higher stone-free rates and shorter operative times compared to middle calyx puncture, with comparable safety profiles. Prospective trials are needed to validate these findings.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer